Page last updated: 2024-08-23

lovastatin and Peripheral Vascular Diseases

lovastatin has been researched along with Peripheral Vascular Diseases in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	2 (66.67)	18.2507
2000's	1 (33.33)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Ahn, C; Aronow, WS	1
Mattila, SP; Tikkanen, MJ; Tilly-Kiesi, M	1
Kroon, AA; Stalenhoef, AF; van Asten, WN	1

Trials

1 trial(s) available for lovastatin and Peripheral Vascular Diseases

Article	Year
Effect of apheresis of low-density lipoprotein on peripheral vascular disease in hypercholesterolemic patients with coronary artery disease. Annals of internal medicine, 1996, Dec-15, Volume: 125, Issue:12 Topics: Adult; Aged; Anticholesteremic Agents; Blood Component Removal; Cholesterol, LDL; Combined Modality Therapy; Coronary Artery Disease; Disease Progression; Enzyme Inhibitors; Hemodynamics; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Lovastatin; Male; Middle Aged; Peripheral Vascular Diseases; Simvastatin	1996

Article

Year

Effect of apheresis of low-density lipoprotein on peripheral vascular disease in hypercholesterolemic patients with coronary artery disease.

Annals of internal medicine, 1996, Dec-15, Volume: 125, Issue:12

Topics: Adult; Aged; Anticholesteremic Agents; Blood Component Removal; Cholesterol, LDL; Combined Modality Therapy; Coronary Artery Disease; Disease Progression; Enzyme Inhibitors; Hemodynamics; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Lovastatin; Male; Middle Aged; Peripheral Vascular Diseases; Simvastatin

1996

Other Studies

2 other study(ies) available for lovastatin and Peripheral Vascular Diseases

Article	Year
Frequency of new coronary events in older persons with peripheral arterial disease and serum low-density lipoprotein cholesterol > or = 125 mg/dl treated with statins versus no lipid-lowering drug. The American journal of cardiology, 2002, Oct-01, Volume: 90, Issue:7 Topics: Aged; Aged, 80 and over; Anticholesteremic Agents; Cholesterol, HDL; Cholesterol, LDL; Female; Follow-Up Studies; Health Services for the Aged; Humans; Hypercholesterolemia; Incidence; Lovastatin; Male; Middle Aged; Myocardial Infarction; New York; Peripheral Vascular Diseases; Pravastatin; Prospective Studies; Simvastatin; Treatment Outcome; Triglycerides	2002
Effects of lovastatin on high-density lipoprotein subfractions in hypercholesterolemic patients with peripheral vascular disease. Angiology, 1993, Volume: 44, Issue:2 Topics: Adult; Apolipoprotein A-I; Apolipoprotein A-II; Arteriosclerosis; Case-Control Studies; Cholesterol, HDL; Female; Humans; Hypercholesterolemia; Intermittent Claudication; Lipids; Lipoproteins, HDL; Lipoproteins, HDL2; Lipoproteins, HDL3; Lovastatin; Male; Middle Aged; Peripheral Vascular Diseases	1993

Article

Year

Frequency of new coronary events in older persons with peripheral arterial disease and serum low-density lipoprotein cholesterol > or = 125 mg/dl treated with statins versus no lipid-lowering drug.

The American journal of cardiology, 2002, Oct-01, Volume: 90, Issue:7

Topics: Aged; Aged, 80 and over; Anticholesteremic Agents; Cholesterol, HDL; Cholesterol, LDL; Female; Follow-Up Studies; Health Services for the Aged; Humans; Hypercholesterolemia; Incidence; Lovastatin; Male; Middle Aged; Myocardial Infarction; New York; Peripheral Vascular Diseases; Pravastatin; Prospective Studies; Simvastatin; Treatment Outcome; Triglycerides

2002

Effects of lovastatin on high-density lipoprotein subfractions in hypercholesterolemic patients with peripheral vascular disease.

Angiology, 1993, Volume: 44, Issue:2

Topics: Adult; Apolipoprotein A-I; Apolipoprotein A-II; Arteriosclerosis; Case-Control Studies; Cholesterol, HDL; Female; Humans; Hypercholesterolemia; Intermittent Claudication; Lipids; Lipoproteins, HDL; Lipoproteins, HDL2; Lipoproteins, HDL3; Lovastatin; Male; Middle Aged; Peripheral Vascular Diseases

1993